Texaclear Severe Cough, Cold And Flu Liquid
NDC Package 58809-217-08

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Texaclear Severe Cough, Cold And Flu (choline salicylate, dextromethorphan hydrobromide, guaifenesin) liquids is do not exceed recommended dosage. This formulation utilizes a liquid delivery system. Marketed by Gm Pharmaceuticals, Inc, this product is identified by NDC 58809-217 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
58809-217-08
Package Description
237 mL in 1 BOTTLE, PLASTIC
Product Code
11-Digit Billing Format
58809021708
RxNorm Crosswalk
  • RxCUI: 2670541 - choline salicylate 870 MG / dextromethorphan HBr 20 MG / guaiFENesin 200 MG in 30 mL Oral Solution
  • RxCUI: 2670541 - choline salicylate 29 MG/ML / dextromethorphan hydrobromide 0.667 MG/ML / guaifenesin 6.67 MG/ML Oral Solution
  • RxCUI: 2670541 - choline salicylate 870 MG / dextromethorphan HBr 20 MG / guaifenesin 200 MG per 30 ML Oral Solution

Clinical Specifications

Proprietary Name
Texaclear Severe Cough, Cold And Flu
Non-Proprietary Name
Choline Salicylate, Dextromethorphan Hydrobromide, Guaifenesin
Substance Name
Choline Salicylate; Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
Do not exceed recommended dosage. do not take more than 6 doses in any 24-hour period.use enclosed dose cup and keep with productmL= milliliteradults and children 12 years of age and over:30 mL every 4 hours.children under 12 years of age:do not use

Regulatory & Marketing

Labeler Name
Gm Pharmaceuticals, Inc
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
10-25-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58809-217-08 identifies a specific commercial package of 237 ml in 1 bottle, plastic of Texaclear Severe Cough, Cold And Flu, a human over the counter drug labeled by Gm Pharmaceuticals, Inc. This liquid is formulated for oral use and contains choline salicylate; dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Gm Pharmaceuticals, Inc on October 25, 2023. The current certification is valid through December 31, 2026.

How is this Gm Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58809021708. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58809-217-08
11-Digit CMS (5-4-2)
58809-0217-08

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.